What is Beijing Airdoc Technology Co Sloan Ratio %?
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Beijing Airdoc Technology Co's Sloan Ratio %
For the Health Information Services subindustry, Beijing Airdoc Technology Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Airdoc Technology Co's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Beijing Airdoc Technology Co's Sloan Ratio % falls into.
Beijing Airdoc Technology Co Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Beijing Airdoc Technology Co's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -40.437 (Jun. 2023 ) + -104.525 (Dec. 2023 ) = HK$-145.0 Mil.
Beijing Airdoc Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -104.892 (Jun. 2023 ) + 130.455 (Dec. 2023 ) = HK$25.6 Mil.
Beijing Airdoc Technology Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -328.714 (Jun. 2023 ) + -92.546 (Dec. 2023 ) = HK$-421.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Airdoc Technology Co (HKSE:02251) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2023, Beijing Airdoc Technology Co has a Sloan Ratio of 13.61%, indicating there is a warning stage of accrual build up.
Beijing Airdoc Technology Co Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Beijing Airdoc Technology Co (HKSE:02251) Business Description
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02251 has been successfully added to your 